Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

H-Phe-Ser-Arg-Tyr-Ala-Arg-OH acetate

EU orphan designation number: EU/3/16/1662   
Active ingredient: H-Phe-Ser-Arg-Tyr-Ala-Arg-OH acetate
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: QRC Ireland
21 Priory Office Park, Stillorgan, County Dublin, A94 F660, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/06/2016 Orphan designation EMA/OD/011/16 (2016)3417 of 30/05/2016
10/12/2018 Transfer of orphan designation EMA/OD/011/16/T/01 (2018)8626 of 6/12/2018